Pfizer (PFE) Announces Top-Line Results Of Prevenar 13 Phase 3 Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/25/2026

1. NVDA
2. JMKE
3. SPY
4. BABA
5. REF
6. XPEV
7. USO
8. TSLA
9. REAX
10. BA

Go back to Pfizer (PFE) Announces Top-Line Results Of Prevenar 13 Phase 3 Trial
Pfizer Inc. (NYSE: PFE) Delayed: 27.97 -0.1 (0.36%)
Previous Close $28.07    52 Week High $37.39 
Open $28.10    52 Week Low $28.25 
Day High $28.16    P/E 16.95 
Day Low $27.81    EPS $1.65 
Volume 23,823,273